CRDF - Cardiff Oncology Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-05    (Delayed quote data   2025-01-06)
Last
 4.54		 Change
 ⇓ -0.16   (-3.40%)		 Volume
  1,181,211
Open
 4.81		 High
 4.89		 Low
 4.52
8EMA (Daily)
 4.38		 40EMA (Daily)
 3.64		 50EMA (Daily)
 3.51		 STO (Daily)
 48.139		 MACD Hist (Daily)
 0.026
8EMA (Weekly)
 3.927		 40EMA (Weekly)
 3.05		 50EMA (Weekly)
 2.95		 STO (Weekly)
 66.920		 MACD Hist (Weekly)
 0.432
Company Profile
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com